ICD-10-CM Billable Code

M08.479

Pauciarticular juvenile rheumatoid arthritis, unspecified ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Pauciarticular juvenile rheumatoid arthritis (JRA) is a form of juvenile arthritis that primarily affects a small number of joints in children, typically four or fewer. The subtype specified by ICD-10 code M08.479 refers to cases where the ankle and foot are impacted, but without a defined or specific subtype. This condition can cause pain, swelling, and stiffness in the affected joints, potentially impacting a child's mobility and daily activities. While the exact cause of pauciarticular JRA remains unknown, it involves joint inflammation resulting from an abnormal immune response. Early recognition and management are important to minimize joint damage and maintain quality of life.

Causes & Symptoms

Clinical Causes: The exact cause of pauciarticular juvenile rheumatoid arthritis is unknown. It is believed to involve an autoimmune response where the child's immune system mistakenly attacks joint tissues. Genetic factors may play a role, with a higher incidence seen in children with a family history of autoimmune diseases. Environmental triggers, such as infections, might contribute to triggering the immune response, though this association is not definitively established. Certain genetic markers, such as HLA-DRB1, may be associated with an increased risk of developing this condition.

Key Symptoms: Persistent joint swelling, especially in the ankle and foot. Joint stiffness that often worsens after periods of inactivity, such as in the morning. Limited range of motion in the affected joints. Pain or tenderness around the affected joints. Possible warmth and redness over the joints. In some cases, children may experience fever or fatigue, but systemic symptoms are usually absent or mild in pauciarticular types. Intra-articular eye inflammation (uveitis), which can develop without symptoms, requiring regular eye examinations.

Diagnostic & Treatment

Diagnosis Path: Detailed medical history, including duration and pattern of symptoms. Physical examination focusing on affected joints for swelling, warmth, and movement restrictions. Blood tests such as complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) to identify inflammation. Antinuclear antibody (ANA) test, which is often positive in pauciarticular JRA. Imaging studies like X-rays, ultrasound, or MRI to assess joint damage or inflammation. Regular eye examinations to check for uveitis, which may not present symptoms initially.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation. Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, to slow disease progression. Physical therapy and occupational therapy to maintain joint mobility and muscle strength. Assisted devices or orthotics to support affected joints and improve mobility. Regular eye exams to monitor for uveitis; corticosteroid eye drops or systemic treatments if necessary. In some cases, intra-articular corticosteroid injections may be used to reduce inflammation in specific joints. Psychosocial support to help children cope with the emotional aspects of chronic illness.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.479 a billable ICD-10 code?
Yes, M08.479 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.479?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, unspecified ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference